Outcomes Associated with Pharmacist-Led Diabetes Collaborative Drug Therapy Management in a Medicaid Population.
Eman BiltajiMinkyoung YooBrandon T JenningsJennifer P LeiserCarrie McAdam-MarxPublished in: Journal of pharmaceutical health services research : an official journal of the Royal Pharmaceutical Society of Great Britain (2016)
A pharmacist-led diabetes CDTM intervention was associated with improved glycemic control in Medicaid patients, which corresponded with a higher number of primary care visits and observed costs. These findings are consistent with studies not limited to Medicaid, suggesting that CDTM can be effective in type 2 diabetes patients with Medicaid coverage.
Keyphrases
- glycemic control
- type diabetes
- affordable care act
- health insurance
- blood glucose
- primary care
- weight loss
- insulin resistance
- randomized controlled trial
- end stage renal disease
- cardiovascular disease
- ejection fraction
- newly diagnosed
- healthcare
- prognostic factors
- skeletal muscle
- mesenchymal stem cells
- stem cells
- emergency department
- case control
- metabolic syndrome
- general practice
- patient reported outcomes
- electronic health record
- patient reported